Post by etherna

14,158 followers

โญ๐—•๐—ฟ๐—ถ๐—ป๐—ด๐—ถ๐—ป๐—ด ๐—ฅ๐—ก๐—” ๐—ฏ๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—ถ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฐ๐—น๐—ผ๐˜€๐—ฒ๐—ฟ ๐˜๐—ผ ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ As nucleic acid-based therapeutics redefine complex treatment approaches, today marks a step forward in Renal disease. A new milestone in ๐—ฟ๐—ฒ๐—ป๐—ฎ๐—น ๐—ฅ๐—ก๐—” ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€ is now advancing into clinical development. This progression marks an important step in translating RNA-based innovation toward therapeutic application. Through our collaboration with ๐——๐—ฟ๐—ผ๐—ฝ๐˜€๐—ต๐—ผ๐˜ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐˜€, this milestone highlights how integrated mRNA and LNP platforms, combined with scalable manufacturing capabilities, can support transition from early discovery to clinical development. ๐ŸคWeโ€™re proud to be part of this journey and to support the next phase of development. ๐Ÿ”— Learn more: https://lnkd.in/eMJrC6GJ #RNAtherapeutics #nucleicacid #biotech #clinicaltrials #drugdevelopment #partnerships

Post content